Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2006 October;54(5) > Minerva Cardioangiologica 2006 October;54(5):673-7

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS   

Minerva Cardioangiologica 2006 October;54(5):673-7

Copyright © 2006 EDIZIONI MINERVA MEDICA

language: English

Carotid artery stenting: where are we now?

Rabe K., Sievert H.

CardioVascular Center Frankfurt Sankt Katharinen, Frankfurt, Germany


PDF


Carotid artery disease is a frequent risk factor for ischemic stroke. Carotid endarterectomy was considered to be the standard treatment for high graded stenosis until carotid artery stenting (CAS) developed with promising results in early series and randomized trials. At present, stenting is supported in patients at high risk for surgery. Randomized trials analyzing low risk patient groups and studying the long-term results of CAS are necessary and partly underway. Although randomized trials are not yet available, current evidence suggests that cerebral protection devices reduce the number of neurological events. This review discusses the results of randomized trials and clinical series.

top of page